BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 15006016)

  • 1. Focus on aripiprazole.
    Green B
    Curr Med Res Opin; 2004; 20(2):207-13. PubMed ID: 15006016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Aripiprazole use in children and adolescent psychiatric patients].
    Chevreuil C; Polard E; Lemonnier E; Guillemot P; Bentué-Ferrer D;
    Therapie; 2011; 66(2):123-30. PubMed ID: 21635859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Aripiprazole: a new atypical antipsychotic drug].
    Fischer B; Davids E; Gastpar M
    Fortschr Neurol Psychiatr; 2004 Sep; 72(9):497-502. PubMed ID: 15365912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aripiprazole: an overview of a novel antipsychotic.
    Uzun S; Kozumplik O; Mimica N; Folnegović-Smalc V
    Psychiatr Danub; 2005 Jun; 17(1-2):67-75. PubMed ID: 16395846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aripiprazole: pharmacology, efficacy, safety and tolerability.
    Kinghorn WA; McEvoy JP
    Expert Rev Neurother; 2005 May; 5(3):297-307. PubMed ID: 15938662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor reserve-dependent properties of antipsychotics at human dopamine D2 receptors.
    Tadori Y; Forbes RA; McQuade RD; Kikuchi T
    Eur J Pharmacol; 2009 Apr; 607(1-3):35-40. PubMed ID: 19217900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aripiprazole: a new atypical antipsychotic drug.
    Bowles TM; Levin GM
    Ann Pharmacother; 2003 May; 37(5):687-94. PubMed ID: 12708948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe psychotic exacerbation during combined treatment with aripiprazole/haloperidol after prior treatment with risperidone.
    Letmaier M; Painold A; Holl AK; Grohmann R; Vergin H
    Int J Psychiatry Clin Pract; 2012 Jun; 16(2):153-6. PubMed ID: 22211772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET study.
    Mamo D; Graff A; Mizrahi R; Shammi CM; Romeyer F; Kapur S
    Am J Psychiatry; 2007 Sep; 164(9):1411-7. PubMed ID: 17728427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.
    Potkin SG; Saha AR; Kujawa MJ; Carson WH; Ali M; Stock E; Stringfellow J; Ingenito G; Marder SR
    Arch Gen Psychiatry; 2003 Jul; 60(7):681-90. PubMed ID: 12860772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology.
    Shapiro DA; Renock S; Arrington E; Chiodo LA; Liu LX; Sibley DR; Roth BL; Mailman R
    Neuropsychopharmacology; 2003 Aug; 28(8):1400-11. PubMed ID: 12784105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aripiprazole: a review of its use in the management of mania in adults with bipolar I disorder.
    Dhillon S
    Drugs; 2012 Jan; 72(1):133-62. PubMed ID: 22191800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aripiprazole in schizophrenia and schizoaffective disorder: A review.
    Stip E; Tourjman V
    Clin Ther; 2010; 32 Suppl 1():S3-20. PubMed ID: 20152550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine partial agonists: a new class of antipsychotic.
    Lieberman JA
    CNS Drugs; 2004; 18(4):251-67. PubMed ID: 15015905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerability and pharmacokinetics of aripiprazole in children and adolescents with psychiatric disorders: an open-label, dose-escalation study.
    Findling RL; Kauffman RE; Sallee FR; Carson WH; Nyilas M; Mallikaarjun S; Shoaf SE; Forbes RA; Boulton DW; Pikalov A
    J Clin Psychopharmacol; 2008 Aug; 28(4):441-6. PubMed ID: 18626272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aripiprazole: a comprehensive review of its pharmacology, clinical efficacy, and tolerability.
    DeLeon A; Patel NC; Crismon ML
    Clin Ther; 2004 May; 26(5):649-66. PubMed ID: 15220010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aripiprazole: a review of its pharmacology and clinical use.
    Taylor DM
    Int J Clin Pract; 2003; 57(1):49-54. PubMed ID: 12587943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aripiprazole in the treatment of Alzheimer's disease.
    De Deyn PP; Drenth AF; Kremer BP; Oude Voshaar RC; Van Dam D
    Expert Opin Pharmacother; 2013 Mar; 14(4):459-74. PubMed ID: 23350964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Present data and treatment schedule of aripiprazole in the treatment of schizophrenia].
    Limosin F; Azorin JM; Krebs MO; Millet B; Glikman J; Camus V; Crocq MA; Costentin J; Daléry J
    Encephale; 2008 Jan; 34(1):82-92. PubMed ID: 18514155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aripiprazole in combination with other antipsychotic drugs may worsen psychosis.
    Adan-Manes J; Garcia-Parajua P
    J Clin Pharm Ther; 2009 Apr; 34(2):245-6. PubMed ID: 19250146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.